GROUNDBREAKING: Europe to put ‘mechanical hearts’ on sale this year
A French company named Carmat has manufactured these mechanical hearts, and they will be launched into the market during 2021's second quarter.
Authorities in Europe have officially greenlighted the trading of mechanical hearts in the continent. These hearts are designed to assist those with heart issues and act as a lifesaver.
A French company named Carmat has manufactured these mechanical hearts, and they will be launched into the market during 2021’s second quarter.
The technology termed Aeson replicates the biological traits and functions of the human heart. Each of these devices weighs 900 grams and is run by batteries. It has been created to play the role of a pump for blood circulation, just like a natural heart.
Sharing the purpose behind such a creation, the CEO of Carmat Stéphane Piat told Reuters:
The idea behind this heart, which was born nearly 30 years ago, was to create a device that would replace heart transplants, a device that works physiologically like a human heart, one that’s pulsating, self-regulated, and compatible with blood.
As per a French report, the mechanical heart is capable of supporting patients with end-stage biventricular heart failure for years.
Right now, the artificial hearts have only been approved as temporary implants.